Differential HMG-CoA lyase expression in human tissues provides clues about 3-hydroxy-3-methylglutaric aciduria

Abstract3-Hydroxy-3-methylglutaric aciduria is a rare human autosomal recessive disorder caused by deficiency of 3-hydroxy-3-methylglutaryl CoA lyase (HL). This mitochondrial enzyme catalyzes the common final step of leucine degradation and ketogenesis. Acute symptoms include vomiting, seizures and lethargy, accompanied by metabolic acidosis and hypoketotic hypoglycaemia. Such organs as the liver, brain, pancreas, and heart can also be involved. However, the pathophysiology of this disease is only partially understood. We measured mRNA levels, protein expression and enzyme activity of human HMG-CoA lyase from liver, kidney, pancreas, testis, heart, skeletal muscle, and brain. Surprisingly, the pancreas is, after the liver, the tissue with most HL activity. However, in heart and adult brain, HL activity was not detected in the mitochondrial fraction. These findings contribute to our understanding of the enzyme function and the consequences of its deficiency and suggest the need for assessment of pancreatic damage in these patients.

[1]  T. M. Lewin,et al.  Regulation of mitochondrial sn-glycerol-3-phosphate acyltransferase activity: response to feeding status is unique in various rat tissues and is discordant with protein expression. , 2001, Archives of biochemistry and biophysics.

[2]  I. Segal,et al.  Evidence of toxic metabolite stress in black South Africans with chronic pancreatitis. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[3]  D. Danks,et al.  The urinary organic acid profile associated with 3-hydroxy-3-methylglutaric aciduria. , 1976, Clinica chimica acta; international journal of clinical chemistry.

[4]  Shantilal N. Shah Cytosolic 3-hydroxy-3-methyl glutaryl coenzyme a synthase in rat brain: Properties and developmental change , 1982, Neurochemical Research.

[5]  S. Wysocki,et al.  3-Hydroxy-3-methylglutaric aciduria: deficiency of 3-hydroxy-3-methylglutaryl coenzyme A lyase. , 1976, Clinica chimica acta; international journal of clinical chemistry.

[6]  P. Leung,et al.  Role of oxidative stress in pancreatic inflammation. , 2009, Antioxidants & redox signaling.

[7]  M. J. MacDonald,et al.  Feasibility of Pathways for Transfer of Acyl Groups from Mitochondria to the Cytosol to Form Short Chain Acyl-CoAs in the Pancreatic Beta Cell* , 2007, Journal of Biological Chemistry.

[8]  D. Williamson,et al.  Physiological roles of ketone bodies as substrates and signals in mammalian tissues. , 1980, Physiological reviews.

[9]  S. Wysocki,et al.  3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: A review , 1986, Journal of Inherited Metabolic Disease.

[10]  D. Heresbach,et al.  Serum measurements of pancreatitis associated protein in active Crohn's disease with ileal location. , 2008, Gastroenterologie clinique et biologique.

[11]  M. Lane,et al.  Intracellular localization of the 3-hydroxy-3-methylglutaryl coenzme A cycle enzymes in liver. Separate cytoplasmic and mitochondrial 3-hydroxy-3-methylglutaryl coenzyme A generating systems for cholesterogenesis and ketogenesis. , 1975, The Journal of biological chemistry.

[12]  J. T. Clarke,et al.  Pancreatitis in patients with organic acidemias. , 1994, The Journal of pediatrics.

[13]  Shupei Wang,et al.  Medical aspects of ketone body metabolism. , 1995, Clinical and investigative medicine. Medecine clinique et experimentale.

[14]  S. Wysocki,et al.  3-Hydroxy-3-methylglutaric aciduria: 3-hydroxy-3-methylglutaryl-coenzyme A lyase levels in leucocytes. , 1976, Clinica chimica acta; international journal of clinical chemistry.

[15]  A. Beaudet,et al.  Atypical presentation and neuropathological studies in 3‐hydroxy‐3‐methylglutaryl–CoA lyase deficiency , 1986, Annals of neurology.

[16]  O. Søvik,et al.  A child with acute pancreatitis and recurrent hypoglycemia due to 3-hydroxy-3-methylglutaryl-CoA lyase deficiency , 1984, European Journal of Pediatrics.

[17]  T. Nakahata,et al.  Cerebral infarction and pancreatitis: possible complications of patients with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency , 2000, Journal of Inherited Metabolic Disease.

[18]  K. Jeejeebhoy,et al.  The management of conditioned nutritional requirements in heart failure , 2006, Heart Failure Reviews.

[19]  K. Taylor,et al.  Effects of ketone bodies on insulin release and islet-cell metabolism in the rat. , 1983, The Biochemical journal.

[20]  P. Puolakkainen,et al.  Pancreatitis associated protein as an early marker of acute pancreatitis. , 1996, Gut.

[21]  R. Chalmers,et al.  Urinary Excretion of l-Carnitine and Acylcarnitines by Patients with Disorders of Organic Acid Metabolism: Evidence for Secondary Insufficiency of l-Carnitine , 1984, Pediatric Research.

[22]  D. Zafeiriou,et al.  3-Hydroxy-3-methylglutaryl coenzyme a lyase deficiency with reversible white matter changes after treatment. , 2007, Pediatric neurology.

[23]  T. Yılmaz,et al.  Ketone bodies and islet function: 86Rb handling and metabolic data. , 1990, The American journal of physiology.

[24]  C. Pérez-Cerdá,et al.  A nonsense mutation in the exon 2 of the 3-hydroxy-3-methylglutaryl coenzyme A lyase (HL) gene producing three mature mRNAs is the main cause of 3-hydroxy-3-methylglutaric aciduria in European Mediterranean patients. , 1998, Archives of biochemistry and biophysics.

[25]  H. Miziorko,et al.  3-Hydroxy-3-methylglutaryl-CoA lyase is present in mouse and human liver peroxisomes. , 1994, The Journal of biological chemistry.

[26]  N. Urgancı,et al.  A rare cause of hepatomegaly: 3-hydroxy-3-methylglutaryl coenzyme-a lyase deficiency. , 2001, Journal of pediatric gastroenterology and nutrition.

[27]  G. Leipnitz,et al.  Striatum is more vulnerable to oxidative damage induced by the metabolites accumulating in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency as compared to liver , 2009, International Journal of Developmental Neuroscience.

[28]  B. Puisac,et al.  Ten novel HMGCL mutations in 24 patients of different origin with 3‐hydroxy‐3‐methyl‐glutaric aciduria , 2009, Human mutation.

[29]  M. J. Coon,et al.  The enzymatic cleavage of beta-hydroxy-beta-methylglutaryl coenzyme A to acetoacetate and acetyl coenzyme A. , 1955, The Journal of biological chemistry.

[30]  K. Gibson,et al.  3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: review of 18 reported patients , 1988, European Journal of Pediatrics.

[31]  M. Wajner,et al.  The role of oxidative damage in the neuropathology of organic acidurias: Insights from animal studies , 2004, Journal of Inherited Metabolic Disease.

[32]  A. Munnich,et al.  Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease , 2009, Human mutation.

[33]  J. McGarry,et al.  Ketogenesis and cholesterol synthesis in normal and neoplastic tissues of the rat. , 1969, The Journal of biological chemistry.

[34]  M. Durán,et al.  Lethal hypoglycemia in a child with a deficiency of 3-hydroxy-3-methylglutarylcoenzyme A lyase. , 1979, The Journal of pediatrics.

[35]  R. Wanders,et al.  Fatal cardiomyopathy associated with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency , 1994, Journal of Inherited Metabolic Disease.

[36]  M. Guzmán,et al.  Ketone body synthesis in the brain: possible neuroprotective effects. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[37]  N. Auestad,et al.  Fatty Acid Oxidation and Ketogenesis by Astrocytes in Primary Culture , 1991, Journal of neurochemistry.

[38]  J. Ezekowitz,et al.  A Case of Dilated Cardiomyopathy Associated with 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG CoA) Lyase Deficiency , 2009, Case reports in medicine.

[39]  I. Campbell,et al.  Effects of glucose and D-3-hydroxybutyrate on human pancreatic islet cell function. , 1985, Clinical science.

[40]  R. Wanders,et al.  3-Hydroxy-3-methylglutaryl-CoA lyase in human skin fibroblasts: study of its properties and deficient activity in 3-hydroxy-3-methylglutaric aciduria patients using a simple spectrophotometric method. , 1988, Clinica chimica acta; international journal of clinical chemistry.

[41]  J. van der Stok,et al.  Metabolic and genetic regulation of cardiac energy substrate preference. , 2007, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.